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Abstract
The thyroid gland is a known but an unusual site for metastatic tumors from various primary sites. Despite the fact
that it is one of the largest vascular organs in the body, clinical and surgical cases have given an incidence of 3 %
of secondary malignances of the organ. Nevertheless, thyroid metastases are not an exceptional finding at autopsy,
they are encountered in 2 % to 24 % of the patients with malignant neoplasm.
Soft tissue sarcomas metastatic to the thyroid are extremely rare as the majority of thyroid metastasis are caused by
tumors of the kidneys, lungs, mammary glands, ovaries , and colon or by melanomas.
We report a case of 22-years-old woman with right leg rhabdomyosarcoma metastatic to the thyroid gland.
Case report
Clinical history
A 22 years old pregnant female (14 weeks) presented
with a rapidly growing soft tissue mass in the right leg.
Pre operative MRI showed a 7x6x5 cm soft tissue mass
at the anterior compartment of the right leg indenting
the neurovascular bundle.
The patient was willing to keep her precious preg-
nancy. Chest X-Ray with lead shield was performed and
was free.
Patient underwent anterior compartmental resection
of the right leg with the post operative pathology proved
to be high grade pleomorphic sarcoma consistent with
rhabdomyosarcoma.
The patient was referred to the medical oncology unit
where she agreed to do abortion (16 week) to start . . .
chemotherapy.
During her second follow up visit- one month later- at
our surgical oncology outpatient clinic , she complained
of dyspneaic manifestations with neck swelling.
Neck ultra sound revealed an enlarged right thyroid
lobe with hypoechoic heterogenous nodule measuring 4
x 2 cm with other 2 small hypoechoic nodules in the
same lobe. FNAC from the thyroid nodule proved to be
undifferentiated malignant tumor. All biopsies were sent
to the pathology laboratory, processed and reported as
routine paraffin embedded tissues. Routine histopatho-
logical examination was performed on thin sections
(5 μm) stained with H&E.
Patient underwent total thyroidectomy, which showed
to be difficult due to infiltration of the right common ca-




Cut surface from the tumor in the right leg was formed
of tissue mass covered by ellipse of skin. On dissection,
it was firm mass measuring about 7x6x5 cm with
heterogenous grayish white to tan brown cut surface and
surrounded by muscle fibers.
The thyroidectomy specimen showed the right lobe to
be enlarged compared to left lobe, having irregular sur-
face and, on cut section, showed firm grayish white infil-
trative growth.
Light microscopy
The tumor of the right leg appeared as high-grade ma-
lignant tumor tissue. It was formed of intersecting fasi-
cles and diffuse proliferation of highly atypical spindle
shaped to polygonal tumor cells. They exhibited moder-
ate amount of eosinophilic cytoplasm, vesicular nuclei
and prominent nucleoli. Some tumor giant cells were
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Figure 1 Total Thyroidectomy, the right lobe shown to be large
with infiltration of Rt common carotid artery.
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Immunohistochemical staining was performed using
antibodies against vimentin, desmin, s100, SMA and CK.
The procedures were done according to the maunfacture’s
instructions (Dako,Glostrup, Denmark). The tumour cells’
cytoplasm were positively stained for vimentin, desmin
and SMA. No immunoreactivity was observed for CK or
S100. Vimentin immunoreactivity was found to be more
diffusing compared to that of desmin.
The subsequent thyroid FNA revealed, in cell block
preparations, malignant cells of similar nature asFigure 2 The sarcoma tissue invades between the thyroid follicles (H&
(H&E x200), (B), diffuse immunoreactivity to vimentin (DAB peroxidasdescribed in the original specimen. The cells were posi-
tive for vimentin and negative for CK, a picture confirm-
ing the sarcomatous nature of the neoplasm.
The thyroidectomy specimen showed diffuse infiltra-
tion of the thyroid tissue by similar tumour (Figure 2A
& 2B), which showed also identical immunorecativty to
the original specimen. There were positivity for vimen-
tin, desmin (Figure 2C & 2D) and negative CK staining.
All the procedures of this work were done following
the approval of the ethical committee of Mansoura
University.Discussion
Rhabdomyosarcoma is a malignant soft-tissue sarcoma
believed to develop from undifferentiated mesenchymal
cells destined for a skeletal muscle lineage [1,2]. It is a
highly aggressive tumor with a tendency for advanced
and disseminated disease early in its course [3]. Whereas
rhabdomyosarcoma is a common childhood malignancy,
it is exceedingly rare in adults, accounting for around
2 % to 5 % of adult soft-tissue sarcomas [4].
Though uncommon in adults, rhabdomyosarcoma
tends to be more aggressive and more resistant to
chemotherapy than its childhood counterpart [4].
Metastasis to the thyroid gland is not as rare as previ-
ously believed. Its incidence has been shown, in autopsy
series, to be more than the incidence of primary thyroid
malignancy [5].
The overall incidence, not surprisingly, varies from
1.25 % in unselected autopsy series to 24 % in autopsy of
patients with widespread malignant neoplasm [6].E x100) (A). The tumour cells show significant pleomorphism
e x100) (C) and desmin (DAB peroxidase x200) (D).
In both clinical and autopsy series, renal cell, breast
and lung carcinomas are the most frequent sources of
metastases to the thyroid [7,8]. Although thyroid metas-
tases are possibly more common than primary thyroid
carcinoma (as indicated by autopsy series), they are less
of a clinical problem [9].
Thyroid metastasis may be the initial evidence of dis-
ease or perhaps the first presentation of recurrent dis-
ease [9].
Thyroid nodules in a patient with a history of malig-
nancy can pose a diagnostic challenge, particularly if
they present many years after the initial tumour.. It has
been the experience of other institutions that in a pa-
tient with a history of cancer, a malignant thyroid nodule
is much more likely to be metastatic than a new primary
tumour [10].
There is nothing clinically to differentiate thyroid me-
tastases from primary thyroid cancer [10].
FNA biopsy could confirm a clinical suspicion of me-
tastasis to the thyroid gland accurately with low morbid-
ity; it also might help to avoid unnecessary
thyroidectomy in patients with a poor prognosis [11]. In
most instances there is abundant cellularity and the cells
may be typical of the original site, especially when spe-
cific immunohistochemical stains are performed. Nega-
tive staining with antithyroglobulin and anti-calcitonin
antibodies would favour a metastatic tumour [9].
Management depends on the primary site of the ori-
ginal tumour, presence of other metastases and symp-
toms caused by the thyroid mass [9]. Adequate surgical
treatment may prove to be life prolonging or life saving
[12].
Nakhjavani et al stated Shorter mean survival in
patients who were treated non-surgically (25 months),
compared to patients who underwent thyroidectomy
alone or thyroidectomy with adjuvant therapy
(34 months) was reported in one series [13].
Conclusion
Any new thyroid nodule occurring in patients with a
known malignancy, should be considered as a possible
metastatisis until proved otherwise. FNAC is a good tool
to diagnose a metastatic disease.
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